Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Livzon Pharmaceutical Group (LVZPF) Stock Price & Analysis

5 Followers

LVZPF Stock Chart & Stats

$3.80$0.00(0.00%)
At close: 4:00 PM EST
$3$4$5Apr 28Apr 15Oct 16Dec 16Sep 11Mar 26
Day’s Range
$3.80 - $3.80
52-Week Range
$3.80 - $5.22
Previous Close
$3.80
Volume
N/A
Average Volume (3M)
0
Market Cap
$3.70B
Enterprise Value
$17.84B
Total Cash (Recent Filing)
$7.31B
Total Debt (Recent Filing)
$4.20B
Price to Earnings (P/E)
17.8
Beta
0.29
Next Earnings
Mar 31, 2027 (Est.)
EPS Estimate
0.05
Next Dividend Ex-Date
Nov 25, 2026
Dividend Yield
3.86%

Bulls Say, Bears Say

Bulls Say

Strong Profitability

Sustained gross and net margins provide Livzon with a profitable base across its specialty and generic pharmaceutical portfolio. This supports internal funding for research, commercialization, and shareholder returns, while giving the company resilience if industry pricing or demand conditions become less favorable.

Robust Free Cash Flow

Strong free cash flow indicates that reported earnings are translating into meaningful cash generation, strengthening Livzon’s ability to fund operations, product development, and distributions. Cash flow at this level can support financial flexibility over the next several quarters even as growth moderates.

Moderate Leverage

A moderate debt burden and substantial equity base indicate a conservatively financed balance sheet. This reduces pressure from financing obligations and leaves Livzon better positioned to absorb earnings volatility, maintain investment in its pharmaceutical business, and preserve capital allocation flexibility.

Bears Say

Revenue Contraction

Recent revenue contraction shows that Livzon’s established product portfolio is not currently delivering consistent top-line expansion. If this pattern persists, slower scale benefits could limit operating leverage, reduce reinvestment capacity, and make future earnings growth more dependent on margin preservation.

Cooling Capital Efficiency

Lower returns on equity alongside higher leverage suggest that incremental capital is producing less profitability than in earlier periods. This weakens capital efficiency and could constrain sustainable earnings progression unless management improves asset productivity or restores stronger returns on the enlarged financing base.

Variable Cash Conversion

Although absolute free cash flow remains healthy, its recent decline and only moderate operating cash flow coverage indicate that cash conversion is not consistently best-in-class. Continued variability could reduce predictability of internally funded investment and distributions if earnings or working-capital demands change.

Livzon Pharmaceutical Group News

LVZPF FAQ

What was Livzon Pharmaceutical Group’s price range in the past 12 months?
Livzon Pharmaceutical Group lowest stock price was $3.80 and its highest was $5.22 in the past 12 months.
What is Livzon Pharmaceutical Group’s market cap?
Livzon Pharmaceutical Group’s market cap is $3.70B.
When is Livzon Pharmaceutical Group’s upcoming earnings report date?
Livzon Pharmaceutical Group’s next earnings report is estimated for Mar 31, 2027 (not yet confirmed), which is in 139 days.
How were Livzon Pharmaceutical Group’s earnings last quarter?
Livzon Pharmaceutical Group released its earnings results on Oct 23, 2026. The company reported $0.06 earnings per share for the quarter, missing the consensus estimate of $0.072 by -$0.012.
Is Livzon Pharmaceutical Group overvalued?
According to Wall Street analysts Livzon Pharmaceutical Group’s price is currently Undervalued.
Does Livzon Pharmaceutical Group pay dividends?
Livzon Pharmaceutical Group pays an annual dividend of $0.186 which represents an annual dividend yield of 3.86%. See more information on Livzon Pharmaceutical Group dividends here
What is Livzon Pharmaceutical Group’s EPS estimate?
Livzon Pharmaceutical Group’s EPS estimate is 0.05.
How many shares outstanding does Livzon Pharmaceutical Group have?
Livzon Pharmaceutical Group has 299,807,130 shares outstanding.
What happened to Livzon Pharmaceutical Group’s price movement after its last earnings report?
Livzon Pharmaceutical Group reported an EPS of $0.06 in its last earnings report, missing expectations of $0.072. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Livzon Pharmaceutical Group?
Currently, no hedge funds are holding shares in LVZPF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology